Vedanta
is a Massachusetts-based biotechnology company that researches and develops oral therapies for the treatment of autoimmune and infectious diseases... Read moreVedanta
is a Massachusetts-based biotechnology company that researches and develops oral therapies for the treatment of autoimmune and infectious diseases... Read more
2010
PrivateSubsidiary of PureTech Health
News
Jan 27, 2025
PharmaTimes
Vedanta: Vedanta Biosciences reveals Phase 2 VE303 results
Oct 16, 2024
Business Wire
Press Release: Vedanta : Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes
Jul 23, 2024
Citybizlist
Vedanta: Vedanta Biosciences Expands Leadership Team
May 22, 2024
Clinical Trials Arena
Vedanta: Vedanta Biosciences doses first subject in Phase III C. difficile prevention trial
Apr 29, 2024
Yahoo
Vedanta: Vedanta Biosciences to Present at Upcoming Investor Conferences
Mar 06, 2024
Business Wire
Press Release: Vedanta : Vedanta Biosciences to Host Investor Meetings at the Leerink Partners 2024 Global Biopharma Conference
Nov 28, 2023
FinanzNachrichten
Vedanta: Vedanta Biosciences' Key Microbiome Patents Fully Upheld in Three European Opposition Proceedings
Oct 25, 2023
Business Wire
Press Release: Vedanta : Vedanta Biosciences to Host Investor Meetings at the Wells Fargo Virtual Private Biotech Symposium
Oct 10, 2023
Acrofan
Vedanta: Vedanta Biosciences Presents Progress from Two Defined Bacterial Consortia, VE303 for the Prevention of C. difficile and VE707 for the Prevention of G
Oct 05, 2023
Portada
Vedanta: Vedanta Biosciences to Participate at Upcoming Investor Conferences
Vedanta Competitors
1
2
3
4
5
6
7
8
9
10